2010
DOI: 10.1016/j.trim.2010.05.002
|View full text |Cite
|
Sign up to set email alerts
|

The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
41
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(43 citation statements)
references
References 20 publications
2
41
0
Order By: Relevance
“…However, the combination (+49)AA/(AT)LL haplotype (where L=low AT repeat number) was associated to better allograft function than the GG/HH haplotype (where H=high ,i.e. >82-bp repeats) (Kusztal et al, 2010).…”
Section: Discussionmentioning
confidence: 90%
See 3 more Smart Citations
“…However, the combination (+49)AA/(AT)LL haplotype (where L=low AT repeat number) was associated to better allograft function than the GG/HH haplotype (where H=high ,i.e. >82-bp repeats) (Kusztal et al, 2010).…”
Section: Discussionmentioning
confidence: 90%
“…The (+6230) A/G polymorphism (or CT60) in the 3'untraslated region (UTR) of the CTLA-4 gene (rs3087243) has been shown to be associated with the mRNA level of soluble CTLA-4. This later SNP was associated with the levels of membrane and cytoplasmic CTLA-4 in CD4 T lymphocytes from multiple sclerosis patients and with the variation of serum soluble CTLA-4 level in Graves' disease patients (Kusztal et al, 2010). Also in the 3'UTR of CTLA-4 gene, a microsatellite (AT)n has been identified at position 642.…”
Section: Polymorphisms In the Ctla-4 Cd28 And Cd86 Genesmentioning
confidence: 92%
See 2 more Smart Citations
“…Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role for CTLA-4 (Tivol et al, 1995). Several reports strongly suggest that molecular variants in CTLA-4 are involved in T-cell-mediated autoimmune and inflammatory diseases such as type 1 diabetes, autoimmune thyroid disease, multiple sclerosis, systemic lupus erythematosus, and RA (Scalapino et al, 2008;Kusztal et al, 2010;Liu et al, 2010).…”
Section: Introductionmentioning
confidence: 99%